HER-2/Neu and topoisomerase-II-α expression and genic amplification in pancreatic adenocarcinoma

Digestive Diseases and Sciences

Volumn 54, Issue 9, 2009, Pages 2049-2051

  Baiocchi, Gian Luca ^a   Villanacci, Vincenzo ^a   Rossi, Elisa ^a   Gheza, Federico ^a   Portolani, Nazario ^a   Giulini, Stefano M ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING); EPIDERMAL GROWTH FACTOR RECEPTOR 2; ERLOTINIB; TOPOISOMERASE 2 ALPHA; TRASTUZUMAB; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; DNA TOPOISOMERASE II ALPHA; ERBB2 PROTEIN, HUMAN; TUMOR ANTIGEN;

CANCER STAGING; CLINICAL FEATURE; DRUG EFFECT; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; ADENOCARCINOMA; AGED; ENZYMOLOGY; FEMALE; GENETICS; MALE; METABOLISM; NOTE; PANCREAS TUMOR; PROTO ONCOGENE;

ADENOCARCINOMA; AGED; ANTIGENS, NEOPLASM; DNA TOPOISOMERASES, TYPE II, EUKARYOTIC; DNA-BINDING PROTEINS; FEMALE; GENE AMPLIFICATION; GENES, ERBB-2; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; PANCREATIC NEOPLASMS; RECEPTOR, ERBB-2;

EID: 68249146517     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-009-0897-y     Document Type: Letter

References (9)

1. S Sharif RK Ramanathan D Potter K Cieply AM Krasinskas 2008 HER2 gene amplification and chromosome 17 copy number do not predict survival of patients with resected pancreatic adenocarcinoma Dig Dis Sci 53 3026 3032
2. NA Pham J Schwock V Iakovlev G Pond DW Hedley MS Tsao 2008 Immunohistochemical analysis of changes in signaling pathway activation downstream of growth factor receptors in pancreatic duct cell carcinogenesis BMC Cancer 8 43
3. JD Day JA Digiuseppe C Yeo M Lai-Goldman SM Anderson SN Goodman SE Kern RH Hruban 1996 Immonohistochemical evaluation of HER-2/neu expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasms Hum Pathol 27 119 124
4. MW Saif L Karapanagiotou K Syrigos 2007 Genetic alterations in pancreatic cancer World J Gastroenterol 13 33 4423 4430
5. E Tsiambas A Karameris C Dervenis AC Lazaris N Giannakou K Gerontopoulos E Patsouris 2006 HER2/neu expression and gene alterations in pancreatic ductal adenocarcinoma: a comparative immunohistochemistry and chromogenic in situ hybridization study based on tissue microarrays and computerized image analysis JOP 7 3 283 294
6. TA Jarvinen ET Liu 2006 Simultaneous amplification of HER-2 (ERBB2) and topoisomerase II alpha (TOP2A) genes-molecular basis for combination chemotherapy in cancer Curr Cancer Drug Targets 6 579 602
7. DE Hansel R Ashfaq A Rahman D Wanzer CJ Yeo RE Wilentz A Maitra 2005 A subset of pancreatic adenocarcinomas demonstrates coamplification of topoisomerase IIalpha and HER2/neu: use of immunolabeling and multicolor FISH for potential patient screening and treatment Am J Clin Pathol 123 1 28 35
8. AM Senderowicz JR Johnson R Sridhara P Zimmerman R Justice R Pazdur 2007 Erlotinib/gemcitabine for first-line treatment of locally advanced or metastatic adenocarcinoma of the pancreas Oncology 21 14 1696 1706
9. MH Kulke LS Blaszkowsky DP Ryan JW Clark JA Meyerhardt AX Zhu PC Enzinger EL Kwak A Muzikansky C Lawrence CS Fuchs 2007 Capecitabine plus erlotinib in gemcitabine-refractory advanced pancreatic cancer J Clin Oncol 25 30 4787 4792